Asiatic Laboratories (DHA:ASIATICLAB) EV-to-EBIT : (As of May. 27, 2024)

View and export this data going back to 2024. Start your Free Trial

What is Asiatic Laboratories EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Asiatic Laboratories's Enterprise Value is BDT7,502.72 Mil. Asiatic Laboratories does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Asiatic Laboratories's EV-to-EBIT at this moment.

The historical rank and industry rank for Asiatic Laboratories's EV-to-EBIT or its related term are showing as below:

DHA:ASIATICLAB's EV-to-EBIT is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 16.985
* Ranked among companies with meaningful EV-to-EBIT only.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Asiatic Laboratories's Enterprise Value for the quarter that ended in . 20 was BDT0.00 Mil. Asiatic Laboratories does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Asiatic Laboratories's Earnings Yield (Joel Greenblatt) % at this moment.

Asiatic Laboratories EV-to-EBIT Historical Data

The historical data trend for Asiatic Laboratories's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Asiatic Laboratories EV-to-EBIT Chart

Asiatic Laboratories Annual Data

Trend

EV-to-EBIT

Asiatic Laboratories Semi-Annual Data

EV-to-EBIT

Competitive Comparison of Asiatic Laboratories's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Asiatic Laboratories's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Asiatic Laboratories's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Asiatic Laboratories's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Asiatic Laboratories's EV-to-EBIT falls into.

Asiatic Laboratories EV-to-EBIT Calculation

Asiatic Laboratories's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	7502.719	/
	=

Asiatic Laboratories (DHA:ASIATICLAB) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Asiatic Laboratories's Earnings Yield (Joel Greenblatt) % for the quarter that ended in . 20 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: . 20 )	=	EBIT	/	Enterprise Value (Q: . 20 )
	=		/
	=	%

Asiatic Laboratories EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Asiatic Laboratories's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Asiatic Laboratories (DHA:ASIATICLAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Asiatic Laboratories Ltd (DHA:ASIATICLAB) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

Siddeshwari Circular Road, 42-43, Treasure Island (5 th Floor) Shantinagar, Dhaka, BGD, 1217

Website

http://www.asiaticpharma.com

Asiatic Laboratories Ltd is engaged in manufacturing and marketing of a wide range of the rapeutical medicines pharmaceutical products in the categories of Biological, Non-Biological & Sterile Pharmaceutical dosage. It has 80 generic molecules comprising therapeutic classes like antibiotics, antihistamines, bronchodilators, vitamins-minerals, antiulcerants, laxatives, gastroprokinetics, antihematinic, anthelmentics, CNS drugs, respiratory drugs, NSAIDs, dermatological preparations and sterile ophthalmic preparations.

Asiatic Laboratories (DHA:ASIATICLAB) Headlines

No Headlines